Cargando…
Classification of Companion Diagnostics: A New Framework for Biomarker-Driven Patient Selection
BACKGROUND: Modern personalized medicine strategies builds on therapy companion diagnostics to stratify patients into subgroups with differential benefit/risk. In general, stratification for drug response implies a treatment-by-subgroup interaction. This interaction is usually suggested by the drug’...
Autores principales: | Huber, Cynthia, Friede, Tim, Stingl, Julia, Benda, Norbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854277/ https://www.ncbi.nlm.nih.gov/pubmed/34841493 http://dx.doi.org/10.1007/s43441-021-00352-2 |
Ejemplares similares
-
A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations
por: Huber, Cynthia, et al.
Publicado: (2019) -
Companion Diagnostics: State of the Art and New
Regulations
por: Valla, Vasiliki, et al.
Publicado: (2021) -
Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
por: Jørgensen, Jan Trøst, et al.
Publicado: (2022) -
Spline-based procedures for dose-finding studies with active control
por: Helms, Hans-Joachim, et al.
Publicado: (2015) -
A Companion to the Classification of Mental Disorders
por: Cooper, Deborah
Publicado: (2014)